BATS BZX Real-Time Price
As of 10:22am ET
| -0.24 / -1.25%|
The 12 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 18.00, with a high estimate of 39.00 and a low estimate of 14.00. The median estimate represents a -5.31% decrease from the last price of 19.01.
The current consensus among 17 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.